Research Area
Infectious diseases tratment : bacteria, fungus, virus, Mycobacteria Vaccine effect and immune reponse Antibiotic resistance
Team Description
Our research team consists of 6 infectious disease specialists, 1 pediatric infectious disease specialist, 2 clinical research coordinators, and 2 basic researchers. Our team is conducting the following research. 1. Treatment of Staphylococcus aureus infection: Treatment of intractable infections such as prosthetic joint infection and MRSA, breakthrough infection, etc. 2. Diagnosis and treatment of respiratory viral infections: influenza, COVID-19, etc. 3. Mechanism of antibiotic resistance 4. Immune response and effect of infectious disease vaccine: Zoster vaccine, COVID-19 vaccine, etc. 5. Clinical research on new antibiotics, antifungals, antiviral, vaccines, etc.
Team Members
Team Show
Publications
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses. Am J Trop Med Hyg (103(6): 2412–2418, 2020)
Duration of Cultureable SARS-CoV-2 in Hospitalized Patients with COVID-19. N Engl J Med (384(7):671-673, 2021)
Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine. J Clin Med (10(13):2844, 2021)
SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study. Ann Rheum Dis. 2022 Jul 25:annrheumdis-2022-222689
Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19. J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1094-1100
Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine. Vaccines 2022 Dec 8;10(12):2102.
Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with HealthcareWorkers. Vaccines 2022 Dec 13;10(12):2129.
A study on changes in lung function, neutralizing antibodies, and symptoms of adult patients hospitalized with COVID-19. Korean J Intern Med 2023 Jan;38(1):101-112.